Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts

PURPOSE: Recent studies demonstrate that addition of neoadjuvant (NA) carboplatin (Cb) to anthracycline/taxane chemotherapy improves pathological complete response (pCR) in triple negative breast cancer (TNBC). Effectiveness of anthracycline-free, platinum combinations in TNBC is not well known. Her...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, Jose Angel, Ward, Claire, Connor, Carol S., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Augusti, Picornell, Antoni C., del Monte-Millán, Maria, Gonzalez-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortes, Javier, Fuentes, Hugo, Bretel, Denisse, Márquez-Rodas, Iván, Perou, Charles M., Wagner, Jamie L., Mammen, Joshua V., McGinness, Marilee K., Klemp, Jennifer R., Amin, Amanda L., Fabian, Carol J., Heldstab, Jaimie, Godwin, Andrew K., Jensen, Roy A., Kimler, Bruce F., Khan, Qamar J., Martin, Miguel
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5156592/
https://ncbi.nlm.nih.gov/pubmed/27301700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-0162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados